Azelastine Hydrochrloride
Generic Name: azelastine hydrochrloride
Manufactured by MEDA PHARMS. Dosage form: SPRAY, METERED. Route: NASAL. Active ingredients: AZELASTINE HYDROCHRLORIDE (0.1%). Application: NDA022371.
Overview
Manufactured by MEDA PHARMS. Dosage form: SPRAY, METERED. Route: NASAL. Active ingredients: AZELASTINE HYDROCHRLORIDE (0.1%). Application: NDA022371.
Dosage
Available as spray, metered for nasal use.
Related Medications
Dronedarone
dronedarone
Antiarrhythmic [EPC]
11 DESCRIPTION Dronedarone HCl is a benzofuran derivative with the following chemical name: N -{2-butyl-3-[4-(3-dibutylaminopropoxy)benzoyl]benzofuran-5-yl} methanesulfonamide, hydrochloride. Dronedarone HCl is a white fine powder that is practically insoluble in water and freely soluble in methylene chloride and methanol. Its empirical formula is C 31 H 44 N 2 O 5 S, HCl with a relative molecular mass of 593.2. Its structural formula is: MULTAQ is provided as tablets for oral administration.
Sulfacetamide Sodium Monohydrate
sulfacetamide sodium monohydrate
Dosage form: POWDER. Active ingredients: SULFACETAMIDE SODIUM (1 kg/kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Lazertinib
lazertinib
Kinase Inhibitor [EPC]
11 DESCRIPTION LAZCLUZE ® tablets contain lazertinib, a kinase inhibitor for oral use. Lazertinib is present as lazertinib mesylate hydrate with a molecular weight of 668.77 and molecular formula of C 30 H 34 N 8 O 3 ∙CH 4 O 3 S∙H 2 O. The chemical name is N -[5-[[4-[4-[(Dimethylamino)methyl]-3-phenyl-1 H -pyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-(morpholin-4-yl)phenyl]acrylamide methanesulfonate hydrate (1:1:1).
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.